Brain and central nervous system cancer: clinical quality performance indicators - engagement document

Guidance to our consultation on brain and central nervous system cancer clinical quality performance indicators which is taking place in January and February 2024.


8. Areas for Future Consideration

The Brain/CNS Cancer QPI Groups have not able to identify sufficient evidence, or determine appropriate measurability specifications to address all areas felt to be of key importance in the treatment of Brain/CNS Cancer, and therefore in improving the quality of care for patients affected by Brain/CNS Cancer.

The following areas for future consideration have been raised across the lifetime of the Brain/CNS Cancer QPIs:

  • Access to Psychology and Psychiatry Services for Assessment and Treatment of Emotional Disorders.
  • Access to physical/psychological and cognitive/functional needs assessment.
  • Neurological functional needs assessment.
  • Access to appropriate palliative care support.
  • Compliance with neuro-radiology sequence guidance.
  • Further molecular testing (e.g. TERT)
  • Use of the Patient Concerns Inventory (PCI) in Brain/CNS cancer patients
  • Surgical Volumes

Contact

Email: cancerpolicyteam@gov.scot

Back to top